<DOC>
	<DOCNO>NCT00679302</DOCNO>
	<brief_summary>The purpose study determine antibiotic require management skin abscess follow incision drainage .</brief_summary>
	<brief_title>Utility Trimethoprim-sulfamethoxazole Use Skin Abscess Management</brief_title>
	<detailed_description>This double-blind , randomize control trial urban pediatric emergency department . Sample size ( 162 ) base threshold equivalence 7 % ( Î± = 0.05 , power = 80 % ) . Inclusion criterion : non-toxic , immunocompetent , 3 month 18 year old , English-speaking patient clinical ultrasound identify skin abscess antibiotic . Patients block randomize receive placebo trimethoprim/sulfamethoxazole follow incision drainage . Follow-up call 2-3 day &amp; repeat visit call 10-14 day . Treatment failure define : persistent erythema , tenderness , and/or drain lesion . New lesion define : primary resolution development new lesion ( furuncle , carbuncle abscess ) different location . Compliance evaluate return study medication patient report .</detailed_description>
	<mesh_term>Abscess</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Skin Diseases , Infectious</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Aluminum hydroxide , magnesium hydroxide , drug combination</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Simethicone</mesh_term>
	<criteria>nontoxic patient immunocompetent patient 3 month 18 year old Englishspeaking patient skin abscess antibiotic toxic patient immunocompromising comorbidities less 3 month old old 18 year age nonenglish speaking antibiotic</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>skin abscess</keyword>
	<keyword>CA-MRSA</keyword>
</DOC>